Skip to main content

Table 1 Demographic and clinical characteristics of all eyes

From: Myopic foveal detachment associated with pachychoroid characteristics

No.

Age

Sex

R/L

Follow up

(Months)

Initial

Snellen BCVA

Final

Snellen BCVA

Refractive error

META-PM classification (chorioretinal atrophy)

Height of SRF at first visit (Ī¼m)

Treatment

PDT/

Intravitreal anti-VEGF injection

Treatment response at final visit

Myopic CSC group

ā€ƒ1

43

F

R

11

20/50

20/32

āˆ’17

Patchy

15

0/6

Recurred

ā€ƒ2

43

F

L

11

20/32

20/25

āˆ’14

Patchy

40

Untreated

Not changed

ā€ƒ3

46

M

R

88

20/32

20/25

āˆ’5.5

Diffuse

37

Untreated

Disappeared

ā€ƒ4

27

M

L

5

20/25

20/20

āˆ’6.5

Diffuse

48

1/9

Complete

ā€ƒ5

67

F

R

93

20/100

20/63

āˆ’7.75

Diffuse

97

1/0

Complete

ā€ƒ6

56

M

R

1

20/80

20/63

āˆ’4.75

Diffuse

112

1/0

Not available

ā€ƒ7

40

F

L

7

20/25

20/32

āˆ’8

Diffuse

136

1/2

Incomplete

ā€ƒ8

69

F

R

64

20/40

20/63

āˆ’6.25

Diffuse

67

Untreated

Not changed

Myopic PNV group

ā€ƒ9

69

F

L

64

20/40

20/63

āˆ’6

Diffuse

113

2/5

Incomplete

ā€ƒ10

59

F

R

21

20/63

20/40

āˆ’3

Tessellated

102

0/5

Complete

ā€ƒ11

59

M

R

99

20/63

20/100

āˆ’4.75

Diffuse

78

3/18

Incomplete

ā€ƒ12

32

F

R

21

20/20

20/20

āˆ’9

Diffuse

61

1/1

Complete

ā€ƒ13

46

F

L

7

20/25

20/32

āˆ’5

Diffuse

117

0/1

Refractory

ā€ƒ14

46

M

L

12

20/32

20/25

āˆ’12.5

Diffuse

42

0/5

Incomplete

ā€ƒ15

48

M

L

55

20/20

20/20

āˆ’9.5

Diffuse

35

0/2

Complete

  1. R/L Right eye/Left eye, CSC Central serous chorioretinopathy, PNV Pachychoroid neovasculopathy, BCVA Best corrected visual acuity, META-PM META-analysis for Pathologic Myopia, SRF Subretinal fluid, PDT Photodynamic therapy, VEGF Vascular endothelial growth factor